Sugammadex is the first and so far only drug in a new class of muscle relaxant reversal drugs. Known as a selective relaxant bind- ing agent (SRBA), sugammadex offers a unique mechanism in that it encapsulates the muscle-relaxant molecule, rendering it inac- tive. The complex formed is eliminated. This is a form of chemical [agonism/antagonism], because no direct receptor action is evident.
Answer
antagonism
Question
Sugammadex is the first and so far only drug in a new class of muscle relaxant reversal drugs. Known as a selective relaxant bind- ing agent (SRBA), sugammadex offers a unique mechanism in that it encapsulates the muscle-relaxant molecule, rendering it inac- tive. The complex formed is eliminated. This is a form of chemical [agonism/antagonism], because no direct receptor action is evident.
Answer
?
Question
Sugammadex is the first and so far only drug in a new class of muscle relaxant reversal drugs. Known as a selective relaxant bind- ing agent (SRBA), sugammadex offers a unique mechanism in that it encapsulates the muscle-relaxant molecule, rendering it inac- tive. The complex formed is eliminated. This is a form of chemical [agonism/antagonism], because no direct receptor action is evident.
Answer
antagonism
If you want to change selection, open original toplevel document below and click on "Move attachment"
Parent (intermediate) annotation
Open it gs. Known as a selective relaxant bind- ing agent (SRBA), sugammadex offers a unique mechanism in that it encapsulates the muscle-relaxant molecule, rendering it inac- tive. The complex formed is eliminated. This is a form of chemical <span>antagonism, because no direct receptor action is evident.<span><body><html>
Original toplevel document (pdf)
cannot see any pdfs
Summary
status
not learned
measured difficulty
37% [default]
last interval [days]
repetition number in this series
0
memorised on
scheduled repetition
scheduled repetition interval
last repetition or drill
Details
No repetitions
Discussion
Do you want to join discussion? Click here to log in or create user.